Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Joris, Berwaerts"'
Autor:
Louise Wray, Joris Berwaerts, David Critchley, Kerry Hyland, Cuiping Chen, Ching Thai, Bola Tayo
Publikováno v:
Clinical Pharmacology in Drug Development.
Autor:
Jacqueline Nicholas, Fred Lublin, Sylvia Klineova, Joris Berwaerts, Robert Chinnapongse, Daniel Checketts, Sajida Javaid, Joshua R. Steinerman
Publikováno v:
Multiple Sclerosis and Related Disorders. 75:104745
Autor:
Heng-Keang Lim, Jie Chen, Wing Lam, Yong Gong, Laurent Leclercq, Jose Silva, Rhys Salter, Joris Berwaerts, Cathy K. Gelotte, Amy M. Vakil, Gary E. Eichenbaum, Edwin K. Kuffner, Christopher M. Flores
Publikováno v:
Regulatory Toxicology and Pharmacology. :105379
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2011, Iss default, Pp 93-101 (2011)
Srihari Gopal1, Joris Berwaerts1, Isaac Nuamah1, Kasem Akhras2, Danielle Coppola1, Ella Daly1, David Hough1, Joseph Palumbo11Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA; 2Johnson & Johnson Pharmaceutical Services, L
Externí odkaz:
https://doaj.org/article/45d7582590bb4d0e9e153426d5bfd21f
Autor:
Cathy K. Gelotte, Amy M. Vakil, Joris Berwaerts, Brenda A. Zimmerman, Gary E. Eichenbaum, Christopher M. Flores, Edwin K. Kuffner
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 134
JNJ-10450232 (NTM-006) is a new molecular entity that comprises structural similarities to acetaminophen and provides comparable analgesia in animals and humans without causing the hepatotoxicity associated with acetaminophen overdose in preclinical
Publikováno v:
Epilepsia
Objective The pharmacokinetics (PK) and safety of single oral 750‐mg doses of a plant‐derived pharmaceutical formulation of highly purified cannabidiol (CBD; Epidiolex in the USA and Epidyolex in Europe; 100‐mg/mL oral solution) were assessed i
Publikováno v:
The Journal of Clinical Pharmacology. 56:683-692
The objective of these 2 phase 1, open-label, 2-treatment, single-sequence studies was to evaluate the effect of repeated oral doses of divalproex sodium extended-release (ER) on the pharmacokinetics (PK) of a single dose of paliperidone ER in health
Autor:
Adam Savitz, David Hough, Srihari Gopal, Isaac Nuamah, José Antonio Buron Vidal, An Vermeulen, Paulien Ravenstijn, Joris Berwaerts, Partha Nandy, Mahesh N. Samtani
Publikováno v:
Current Medical Research and Opinion. 31:2043-2054
This commentary summarizes recommended dosing strategies for a recently developed 3 monthly long-acting injectable 1 (LAI) formulation of paliperidone palmitate (PP3M) for the treatment of schizophrenia in adults.Recommendations for different dosing
Autor:
Joris Berwaerts, Andrew Friedman, M. Soledad Cepeda, Greg Mastrogiovanni, Daniel Fife, Yingli Yuan
Publikováno v:
The American Journal of Drug and Alcohol Abuse
Background: Doctor shopping, defined by filling overlapping prescriptions from more than one prescriber at more than two pharmacies, is a way to obtain scheduled medications for diversion or abuse. Little is known about how far attention deficit hype
Autor:
Joris Berwaerts, Adriaan Cleton, Herta Crauwels, An Vandebosch, Virginie Herben, Stefaan Rossenu, Marc De Meulder, Bart Remmerie, Marielle Eerdekens, Igor Francetic, David Hough
Publikováno v:
Clinical Pharmacology in Drug Development. 4:270-278
Paliperidone palmitate (PP) is a once-monthly long-acting injectable antipsychotic approved for the treatment of schizophrenia in many countries. To evaluate the different injection-site options, we compared the pharmacokinetic profile of paliperidon